Mark Bodenrader

Insider Reports History

Entity
Individual
Location
C/O Cerevel Therapeutics Holdings Inc., 131 Dartmouth Street Suite 502, Boston, MA
Signature
/s/ Mark Bodenrader
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Bodenrader:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Senior Vice President, Finance and Chief Accounting Officer Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Senior Vice President, Finance and Chief Accounting Officer Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Senior Vice President, Finance and Chief Accounting Officer Stock Option (Right to Buy) 0 Aug 1, 2024 Direct

Insider Reports Filed by Mark Bodenrader

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 3 $0 4 Aug 5, 2024 Senior Vice President, Finance and Chief Accounting Officer
CERE Cerevel Therapeutics Holdings, Inc. Jan 19, 2024 1 $0 4 Jan 23, 2024 Title: Senior Vice President, Finance and Chief Accounting Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 19, 2023 5 -$327K 4 Dec 21, 2023 Title: Senior Vice President, Finance and Chief Accounting Officer
CERE Cerevel Therapeutics Holdings, Inc. Jun 1, 2023 3 -$62.4K 4 Jun 5, 2023 Title: Senior Vice President, Finance and Chief Accounting Officer
CERE Cerevel Therapeutics Holdings, Inc. Feb 6, 2023 2 $0 4 Feb 8, 2023 Officer
CERE Cerevel Therapeutics Holdings, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Title: Interim Chief Financial Officer, Vice President, Finance and Chief Accounting Officer
CERE Cerevel Therapeutics Holdings, Inc. Feb 9, 2022 1 $0 4 Feb 11, 2022 Title: Interim Chief Financial Officer, Vice President, Finance and Chief Accounting Officer